Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
BETHESDA, Md.--(BUSINESS WIRE)--$IQMD--Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) (the “Company”) announced today that it has postponed the Company’s Special Meeting of Stockholders to be held on February 3, 2023, at 9:30 a.m. Eastern Time until